[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363430-105":59,"doc-detail-363430-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","unraveling-diabetes-mellitus-driven-tumorigenesis-from-pathophysiological-mechanisms-to-tailor-made-nanosystems","Unraveling Diabetes Mellitus-Driven Tumorigenesis - From Pathophysiological Mechanisms to Tailor-Made Nanosystems","","Diabetes mellitus (DM) and cancer represent two major global public health challenges, and accumulating evidence links DM hallmarks to tumorigenesis and progression. Hyperactivated insulin/IGF-1 signaling, chronic hyperglycemia, and a persistent inflammatory microenvironment promote cancer development. Existing antidiabetic drugs can influence both blood glucose and the tumor microenvironment but may suffer from poor oral bioavailability, off-target effects, and limited tumor-site accumulation. Nanotechnology-based nanosystems are reviewed for their mechanisms, targeted delivery, integrated diagnostics, oral administration advantages, clinical translation considerations, and future prospects.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-diabetes-mellitus-driven-tumorigenesis-from-pathophysiological-mechanisms-to-tailor-made-nanosystems/363430/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-diabetes-mellitus-driven-tumorigenesis-from-pathophysiological-mechanisms-to-tailor-made-nanosystems/363430.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does diabetes mellitus contribute to tumorigenesis and cancer progression?","Question",{"text":113,"@type":114},"The review explains that hyperactivated insulin/IGF-1 signaling, chronic hyperglycemia, and a persistent inflammatory microenvironment promote cellular proliferation and support a cancer-friendly setting, including via ROS and pro-inflammatory cytokines.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What limitations affect current clinical antidiabetic drugs in treating cancer-related processes?",{"text":118,"@type":114},"Chemically synthesized, biological, and natural antidiabetic drugs may struggle with poor oral bioavailability, off-target side effects, and low drug accumulation at tumor sites during clinical use.",{"name":120,"@type":111,"acceptedAnswer":121},"Why are tailor-made nanosystems highlighted as a promising solution?",{"text":122,"@type":114},"They are described as overcoming traditional delivery barriers by enabling targeted delivery, integrated diagnostics, and improved oral administration of fragile biologics.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363430,1790203016,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nUnraveling Diabetes Mellitus-Driven Tumorigenesis: From Pathophysiological Mechanisms, Therapeutic Drugs to Tailor-Made Nanosystems  \nZhijie Jiang, Yongting Zhou, Mingfei Ma, Mingzhu Huang, Xiaojuan Wang  \nDepartment of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, People’s Republic of China Correspondence: Xiaojuan Wang; Mingzhu Huang, Email [xiaojuanwang1992@zju.edu.cn](xiaojuanwang1992@zju.edu.cn); [hmzj2002@zju.edu.cn](hmzj2002@zju.edu.cn)  \n\n| Abstract: Diabetes mellitus (DM) and cancer are two major global public health challenges. Growing evidence shows that the core features of DM, including hyperactivated insulin/IGF-1 signaling axis, chronic hyperglycemia, and a persistent inflammatory microenvironment, are important factors driving tumorigenesis and progression. Currently available clinical antidiabetic drugs, such as chemically synthesized drugs, biological and natural products, have been proven to achieve a dual therapeutic effect of controlling blood glucose and regulating the tumor microenvironment (TME) . However, these drugs face practical difficulties such as poor oral bioavailability, off-target side effects, and low drug accumulation at tumor sites in clinical application. To overcome these challenges, nanotechnology offers a highly promising solution. Thus, this review elucidates the mechanisms of DM-driven cancer development and the anti-tumor therapeutic mechanisms of current anti-diabetic drugs. Then, we highlight how tailor-made nanosystems overcome traditional delivery barriers, offering unique advantages in targeted delivery, integrated diagnostics, and the oral administration of fragile biologics. Finally, the clinical translatability, disadvantages, and future prospects of these nanosystems will be briefly discussed. Keywords: diabetes mellitus, nano-delivery systems, cancer development, hyperglycemia, therapeutic agents |\n| --- |\n| Introduction\u003Cbr>Diabetes mellitus (DM) and cancer are two major global public health challenges with high mortality rates, and the prevalence of both conditions continues to rise worldwide. According to the International Diabetes Federation (IDF), the global prevalence of DM was an estimated 537 million cases in 2021, and this number is projected to increase to 783 million by 2045.1 Meanwhile, the World Health Organization (WHO) has reported a significant increase in cancer burden, predicting a rise from 14 million cases in 2012 to 22 million by 2032.2 This upward trend is expected to continue, with global cancer cases estimated to reach at least 592 million by 2035.3 Studies have shown a strong correlation between DM and carcinogenesis, with the most evident correlation reported with type 2 DM (T2DM) .4 Indeed, elevated blood glucose levels have been identified as a key factor in this relationship, as they are known to stimulate the proliferation and progression of cancer cells, thereby increasing cancer incidence.5 For instance, the pancreatic cancer incidence rate among diabetic patients is 54% higher than that in the general population.6 These statistics highlight the critical intersection of DM and cancer, demanding coordinated strategies to manage both diseases effectively.\u003Cbr>Recent evidence further elucidates the mechanisms behind this relationship, suggesting that hyperglycemia promotes tumorigenesis in solid malignancies (eg, pancreatic, liver, and breast cancers (BC)) .7,8 This is driven by several key mechanisms. Firstly, hyperglycemia drives cancer progression through chronic hyperinsulinemia and activation of the insulin-like growth factor-1 (IGF-1) signaling pathway, which promotes cellular proliferation and suppresses apoptosis.9 Secondly, long-term hyperglycemia generates harmful reactive oxygen species (ROS) and pro-inflammatory cytokines (eg, IL-6, TNF-α), which can damage DNA and create a cancer-friendly environ","cbCaiuKcVoQc4Rls","https://ap.wps.com/l/cbCaiuKcVoQc4Rls","pdf",5774885,21,"English","# Introduction\n## Epidemiological link between diabetes and cancer\n## Mechanisms: hyperglycemia, inflammation, and signaling pathways\n## Bidirectional relationship and cancer-treatment induced diabetes\n# Review of therapeutic strategies\n## Anti-diabetic drugs and anti-tumor mechanisms\n## Tailor-made nanosystems for delivery and diagnostics","[{\"question\":\"How does diabetes mellitus contribute to tumorigenesis and cancer progression?\",\"answer\":\"The review explains that hyperactivated insulin/IGF-1 signaling, chronic hyperglycemia, and a persistent inflammatory microenvironment promote cellular proliferation and support a cancer-friendly setting, including via ROS and pro-inflammatory cytokines.\"},{\"question\":\"What limitations affect current clinical antidiabetic drugs in treating cancer-related processes?\",\"answer\":\"Chemically synthesized, biological, and natural antidiabetic drugs may struggle with poor oral bioavailability, off-target side effects, and low drug accumulation at tumor sites during clinical use.\"},{\"question\":\"Why are tailor-made nanosystems highlighted as a promising solution?\",\"answer\":\"They are described as overcoming traditional delivery barriers by enabling targeted delivery, integrated diagnostics, and improved oral administration of fragile biologics.\"}]","Unraveling Diabetes Mellitus-Driven Tumorigenesis - From Pathophysiological Mechanisms to Tailor-Made Nanosystems | PDF",1790151213,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88475fc9c9eac57dd609202c4006d365.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9f0ff436c8e5efaaa44652d51af44ea.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6226ad43595ebeb0b8e2fda66f69bf7d.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71535c80c1531c6f83cfa3cdafb77717.webp",980,1268]